Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A ProspeCtive ObseRvatioNal Study of Atogepant Effectiveness in Routine Clinical Practice

NCT06543914 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06543914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06543914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A ProspeCtive ObseRvatioNal Study of Atogepant Effectiveness in Routine Clinical Practice
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
November 26, 2024
Completion date
February 28, 2029
Enrollment
1,314 (actual)
Sites
112

Conditions

As the registry lists them; a condition with its own page is linked.

migraine